Acyclovir Dosing for Herpes Labialis in a 15-Year-Old
For acute treatment of cold sores in a 15-year-old, use acyclovir 400 mg orally 5 times daily for 5 days, initiated at the first sign of prodrome or within 48 hours of lesion onset.
Treatment Approach
The FDA-approved dosing for herpes labialis treatment is not explicitly listed in the drug label 1, but the closest approved indication is intermittent therapy for genital herpes at 200 mg every 4 hours, 5 times daily for 5 days 1. However, clinical evidence and guidelines support higher dosing for herpes labialis.
Episodic Treatment Dosing
The most effective regimen based on clinical trials is:
- Acyclovir 400 mg orally 5 times daily for 5 days 2, 3
- Treatment must be initiated within the prodromal stage or within 48 hours of lesion onset for optimal efficacy 4
This dosing reduces:
- Duration of pain by 36% (2.5 days vs 3.9 days with placebo) 2
- Healing time by 27% (8.1 days vs 12.5 days) 2, 3
- Viral shedding significantly 3
Alternative Dosing Considerations
Lower doses (200 mg 5 times daily) have been studied but show less robust clinical benefit 5. The 400 mg dose provides better clinical outcomes for herpes labialis specifically 3.
Chronic Suppressive Therapy
If the patient experiences ≥6 episodes per year, consider suppressive therapy:
- Acyclovir 400 mg orally twice daily 6, 7
- This reduces clinical recurrences by 53% and virologically confirmed recurrences by 71% 6
- Median time to first recurrence extends from 46 days (placebo) to 118 days with suppression 6
Pediatric Considerations
While the FDA label states safety in children under 2 years is not established 1, a 15-year-old can be dosed using adult regimens. For immunocompromised children under 12 years, the recommended dose is 20 mg/kg every 8 hours 8, but for immunocompetent adolescents with herpes labialis, adult dosing is appropriate 8, 4.
Critical Timing
The single most important factor for treatment success is early initiation:
- Ideally during prodrome (tingling, burning sensation)
- No later than 48 hours from lesion onset 4
- Treatment started after vesicle formation is significantly less effective 3
Common Pitfalls to Avoid
- Don't use 200 mg 5 times daily – this lower dose shows minimal clinical benefit for herpes labialis 5
- Don't delay treatment – waiting beyond 48 hours dramatically reduces efficacy 4
- Ensure adequate hydration – acyclovir can cause renal dysfunction, particularly in dehydrated patients 1
- Don't use prophylactic dosing (800 mg twice daily) for episodic treatment – this is only for prevention before known triggers 9
Renal Adjustment
For patients with renal impairment, dose adjustment is required. At normal dosing of 200 mg every 4 hours with creatinine clearance 0-10 mL/min, reduce to 200 mg every 12 hours 1.